Jellatech to Expand Bioidentical Human Collagen Production at New 9,000-Square-Foot Facility
US biotech company Jellatech, a leading innovator in cell-based collagen, announces it has completed construction of its 9,000 square-foot facility in Morrisville, North Carolina. The facility is designed for ongoing research and development and will allow the company to produce its bioidentical collagen for pre-clinical trials at scale, which are crucial for adopting collagen-based applications across various sectors. Just last month, Jellatech launched an updated brand to showcase its mission to advance biomedical applications with human-identical proteins, starting with Type 1 collagen, for applications in the healthcare and longevity sectors. “Our new facility represents a leap forward in our ability to deliver high-quality, consistent, and ethically produced proteins for human health and longevity applications,” said Stephanie Michelsen, founder and CEO of Jellatech. Revolutionizing biotechnology The new …